Table 1.

Patient clinical and followup data and corresponding prognosis classifications

Patient	Grade	Stage	Outcome	Dur.	Outcome group	Prognosis group
						Staging	Gene expression
46	G1	S1	NED	62.6	L	L	L
42	G1	S1	NED	77.3	L	L	L
41	G1	S1	NED	80.3	L	L	L
30	G2	S3	NED	87.1	L	H*	H*
7	G1	S1	NED	92.1	L	L	L
26	G1	S1	NED	96	L	L	L
24	G1	S1	NED	97.3	L	L	L
15	G1	S1	OCD	100.4	L	L	L
32	G1	S2	OCD	110.4	L	L	L
1	G1	S1	NED	111.6	L	L	L
21	G1	S1	NED	114.6	L	L	L
20	G1	S1	NED	115.8	L	L	L
35	G1	S3	NED	120.5	L	H*	L
9	G1	S3	NED	120.9	L	H*	L
3	G1	S1	NED	137.2	L	L	L
29	G3	S3	AWC	89.4	L	H*	L
54	G1	S4	AWC	105.6	L	H*	L
13	G3	S4	Death	3.2	H	H	H
48	G2	S4	Death	4.9	H	H	H
11	G3	S3	Death	18.8	H	H	H
60	G3	S4	Death	20.8	H	H	H
31	G3	S3	Death	22.6	H	H	H
53	G3	S4	Death	26.2	H	H	H
5	G2	S4	Death	31.7	H	H	H
12	G2	S4	Death	33.8	H	H	H
55	G2	S2	Death	55.8	H	L*	H
56	G3	S4	AWC	14.8	U	H	L
58	G3	S4	AWC	16.6	U	H	H
59	G2	S3	NED	41.1	U	H	H

Patient clinical data and corresponding prognostic classifications. Grade and stage information (columns 2 and 3) corresponds to the primary tumor. Outcomes (column 4) are: no evidence of disease (NED), alive with cancer (AWC), other cause of death (OCD), and cancer death. Duration (column 5) is months between nephrectomy and latest outcome assessment. Outcome group (column 6) is the risk group, based on actual patient outcome that was used for predictive gene set generation (L, low risk; H, high risk; U, unknown). Pathology prognosis group (column 7) is based on staging (L, stage I/II; H, stage III/IV). Gene expression prognosis group (column 8) is based on a gene expression prognosis test based on the selected genes.  

¹⁷⁸, deviation in outcome from the predicted risk group.